Crescent Biopharma, Inc. GLYC
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Crescent Biopharma, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies in the pharmaceutical sector. It specializes in advancing treatments that address significant unmet medical needs, often targeting niche or rare diseases. The company’s pipeline and research …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees55
TickerGLYC
Statistics
Market Cap$1.16B
Revenue (TTM)$0
Net Income-$37.9M
Net Margin—
EPS$-0.59
P/E-30.47
P/S—
P/B343.71
EV/EBITDA-43.90
ROE-712.9%
Dividend Yield—
Price$17.95
Data: Twelve Data · Revenue = mcap / P/S